CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ElaPharma introduces a new additive that enhances organ preservation during transplantation. This solution extends the viability of organs beyond 24 hours, significantly improving outcomes for patients and increasing the availability of organs for donation.
One of the most important advances in organ transplantation has been the development of preservation procedures resulting in high quality and efficacy of organ supply and operations.
However, current methods used to preserve organs are limited to a very short period of time (i.e. less than 24h).
And insufficient organ preservation capabilities place important logistical limitation to organ donation which place several constraints on the distance that can be travelled to recover donor transplant.…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
